A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

BIOLOGICAL: Luspatercept

Sponsor

Bristol-Myers Squibb